North American Metabolic Disorder Therapeutics Market Size, Share, Analysis, Industry Report and Forecast 2020-2026

 

North American metabolic disorder therapeutics market is estimated to grow at a CAGR of 7.6% during the forecast period. Growing incidences of metabolic disorders are encouraging the growth of the market. An increasing prevalence of diabetes and obesity have been witnessed in the region owing to the sedentary lifestyle habits. As per the World Health Organization (WHO), since 1975, global obesity has nearly tripled. In 2016, over 1.9 million adults, aged 18 years and more were overweight and among these, 650 million were obese. In 2016, 39% of adults aged 18 years and more were overweight and 13% were obese. A sedentary lifestyle is a major factor for the rising incidence of metabolic syndrome in the region, characterized by low nutrient-dense, foods, and physical inactivity. During the early period of life, this exposure is most potent leads to childhood obesity which is a key risk factor for metabolic syndrome in adults. Rimonabant (Acomplia), dexfenfluramine (Redux), orlistat (Xenical), and sibutramine (Meridia, Reductil), have been registered to treat obesity. More drugs are in clinical trials for metabolic disorders treatment, which is expected to offer a potential scope for market growth. 

Request a Free Sample of our North American Metabolic Disorder Therapeutics Market:  https://www.omrglobal.com/request-sample/north-american-metabolic-disorder-therapeutics-market

Scope of the North American Metabolic Disorder Therapeutics Market

Market Coverage

  • The market number available for 2019-2026
  • Base year- 2019
  • Forecast period- 2020-2026
  • Segment Covered- By Therapy and Disease
  • Countries Covered- US and Canada
  • Competitive Landscape- AbbVie, Inc., Alexion Pharmaceuticals, Inc., Pfizer Inc., Eli Lilly & Co., and AstraZeneca plc

A full Report of North American Metabolic Disorder Therapeutics Market is Available at:  https://www.omrglobal.com/industry-reports/north-american-metabolic-disorder-therapeutics-market

Recent Strategic Initiatives in the North American Metabolic Disorder Therapeutics Market

  • In June 2020, Ultragenyx declared the US FDA approval of Dojolvi (triheptanoin). It is a source of fatty acids and calories to treat pediatric and adult patients suffering from long-chain fatty acid oxidation disorders (LC-FAOD). Dojolvi is a synthetic, highly purified, and 7-carbon fatty acid triglyceride particularly aimed to offer medium-chain, odd-carbon fatty acids as an energy source and metabolite replacement for people suffering from LC-FAOD. 
  • In March 2020, Eli Lilly and Co. declared the global licensing and research partnership with Sitryx, a biopharmaceutical company engaged in the development of therapeutics in immuno-inflammation and immuno-oncology. Under the partnership, the companies will study up to four new preclinical targets that are found by Sitryx that could result in potential new medicines for autoimmune diseases. Lilly will make a $10 million equity investment in Sitryx and Sitryx will get an upfront payment of $50 million.

Key questions addressed by the report

  • What is the market growth rate?
  • Which segment dominates the market in the base year?
  • Which segment will project the fastest growth in the market?
  • How COVID-19 impacted the market?

o             Recovery Timeline

o             Deviation from the pre-COVID-19 forecast

o             Most affected region/segment

  • Who is the leader in the market?
  • How players are addressing challenges to sustain growth?
  • Where is the investment opportunity?

North American Metabolic Disorder Therapeutics Market-Segmentation

By Therapy

  • Drug Therapy
  • Gene Therapy
  • Cellular Transplantation
  • Enzyme Replacement Therapy
  • Others

By Disease

  • Obesity
  • Diabetes
  • Lysosomal Storage Disease
  • Hypercholesterolemia
  • Others

North American Metabolic Disorder Therapeutics Market– Segment by Country

  • US
  • Canada

Company Profiles

·         Abbvie Inc.

·         Agios Pharmaceuticals Inc.

·         Alexion Pharmaceuticals, Inc.

·         Amgen Inc.

·         Apotex Inc.

·         BioMarin Pharmaceutical Inc.

·         CymaBay Therapeutics, Inc.

·         Dracen Pharmaceuticals, Inc.

·         Eli Lilly and Co.

·         Intra-Cellular Therapies, Inc.

·         Pfizer Inc.

·         Sigilon Therapeutics, Inc.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/north-american-metabolic-disorder-therapeutics-market

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

For More Information, Visit Orion Market Research

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: info@omrglobal.com

Contact no:  +91 7803040404

Comments

Post a Comment

Popular posts from this blog

European Data Backup and Recovery Market Size, Share, Analysis, Industry Report and Forecast 2019-2025

  European Data Backup and Recovery Market are expected to reach $5.7 billion in 2027, growing at a CAGR of 9.5% during the forecast period (2021-2027). Factors responsible for the growth of the market in Europe are well-developed telecommunication infrastructure, high internet penetration, high adoption of cloud-based devices among people and organization. Regulations regarding the data localization such as GDPR by the European Union and countries own data localization and protection act are providing growth to the market. Major economies which are expected to hold a considerable market are UK, Germany, France, Italy, and Spain. These economies are part of the European Union, which covers most of the continent. The aim of the European Union was to increase economic cooperation and encourage free trade among countries. To Request a Sample of our Report on European Data Backup and Recovery Market :   https://www.omrglobal.com/request-sample/european-data-backup-recovery-...
Read more

Insect Repellent Market Is Likely to Experience a Tremendous Growth by 2031

This informative Insect Repellent Market report provides new method and covers foremost regions such as Latin America, Middle East, North America, Europe, Africa and Asia Pacific. Making most out of the consumer insights and market opportunities, market players can boost up the revenue rate of their business. It also permits key organizations to make communication with customers and know their demands for making right investment in the product development. By increasing the product portfolio by referring the important market data provided in this Insect Repellent Market research report, key players can grow and expand their business forward. Continuously developing customer demands are also described in this global report to help new entrants make required changes in the final product launch and then bring into the market. It becomes easy for key players to prioritize the demands and requirements of target audience and have complete understanding of end-user experience with the help o...
Read more

Asia-Pacific Urban Air Mobility Market Growth, Size, Share, Industry Report and Forecast 2019-2025

The Asia-Pacific urban air mobility market is estimated to grow at a CAGR of 12.6% during the forecast period. The Asia-Pacific urban air mobility market is segmented on the basis of component and operation. Based on the component, the market is further segmented into infrastructure and platform. The infrastructure segment is further segmented into charging stations, traffic management, and others whereas, the platform segment is further classified into air taxi, personal air vehicle, air ambulance, and others. The platform segment dominated the global urban air mobility market. To Request a Sample of our Report on Asia-Pacific Urban Air Mobility Market :   https://www.omrglobal.com/request-sample/asia-pacific-urban-air-mobility-market Asia-Pacific is home to several emerging economies and is seen as the potential market for the UAM owing to growing urbanization coupled with increasing traffic congestion and increasing high-income groups in the region. The growth of the As...
Read more